SearchSearch results for: “”

Advising Friesland Bank on its separation from Stichting Friesland Bank and its merger into Rabobank Nederland.

Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.

Advising several Dutch pension funds in connection with enforcement action taken by the Dutch Central Bank in view of actual or threatened failure to satisfy capital adequacy requirements. 

Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.

Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.

Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.

Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.

Stibbe assisted New Mountain Capital with Luxembourg legal aspects related to the signing of a purchase agreement pursuant to which Grant Thornton Luxembourg will join a new transatlantic professional services platform led by Grant Thornton Advisors LLC.